Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic
In: Beneficial MicrobesSearch for other papers by M. Hell in
Current site
Google Scholar
Search for other papers by C. Bernhofer in
Current site
Google Scholar
Search for other papers by P. Stalzer in
Current site
Google Scholar
Search for other papers by J.M. Kern in
Current site
Google Scholar
Search for other papers by E. Claassen in
Current site
Google Scholar
In the past two years an enormous amount of molecular, genetic, metabolomic and mechanistic data on the host-bacterium interaction, a healthy gut microbiota and a possible role for probiotics in Clostridium difficile infection (CDI) has been accumulated. Also, new hypervirulent strains of C. difficile have emerged. Yet, clinical trials in CDI have been less promising than in antibiotic associated diarrhoea in general, with more meta-analysis than primary papers on CDI-clinical-trials. The fact that C. difficile is a spore former, producing at least three different toxins has not yet been incorporated in the rational design of probiotics for (recurrent) CDI. Here we postulate that the plethora of effects of C. difficile and the vast amount of data on the role of commensal gut residents and probiotics point towards a multistrain mixture of probiotics to reduce CDI, but also to limit (nosocomial) transmission and/or endogenous reinfection. On the basis of a retrospective chart review of a series of ten CDI patients where recurrence was expected, all patients on adjunctive probiotic therapy with multistrain cocktail (Ecologic®AAD/OMNiBiOTiC® 10) showed complete clinical resolution. This result, and recent success in faecal transplants in CDI treatment, are supportive for the rational design of multistrain probiotics for CDI.
-
Bauer, M.P. and Van Dissel, J.T., 2009. Alternative strategies for Clostridium difficile infection. International Journal of Antimicrobial Agents 33: S51-S56.
'Alternative strategies for Clostridium difficile infection ' () 33 International Journal of Antimicrobial Agents : S51 -S56 .
-
Bauer, M.P., Kuijper, E.J., Van Dissel, J.T. and European Society of Clinical Microbiology and Infectious Diseases, 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clinical Microbiology and Infection 15: 1067-1079.
-
Borthakur, A., Gill, R.K., Tyagi, S., Koutsouris, A., Alrefai, W.A., Hecht, G.A., Ramaswamy, K. and Dudeja, P.K., 2008. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. Journal of Nutrition 138: 1355-1359.
'The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells ' () 138 Journal of Nutrition : 1355 -1359 .
-
Brandt, L.J., 2012. Fecal transplantation for the treatment of Clostridium difficile infection. Gastroenterology and Hepatology of CNY 8: 191-194.
'Fecal transplantation for the treatment of Clostridium difficile infection ' () 8 Gastroenterology and Hepatology of CNY : 191 -194 .
-
Brandtzaeg, P. and Pabst, R., 2004. Let's go mucosal: communication on slippery ground. Trends in Immunology 25: 570-577.
'Let's go mucosal: communication on slippery ground ' () 25 Trends in Immunology : 570 -577 .
-
Bron, P.,A., Van Baarlen, P. and Kleerebezem, M., 2012. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nature Reviews Microbiology 10: 66-78.
'Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa ' () 10 Nature Reviews Microbiology : 66 -78 .
-
Cadieux, P.A., Burton, J., Devillard, E. and Reid, G., 2009. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. Journal of Physiology and Pharmacology 60 Suppl. 6: 13-18.
'Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli ' () 60 Journal of Physiology and Pharmacology : 13 -18 .
-
Cartman, S.T., Heap, J.T., Kuehne, S.A., Cockayne, A. and Minton, N.P., 2010. The emergence of ‘hypervirulence’ in Clostridium difficile. International Journal of Medical Microbiology 300: 387-395.
'The emergence of ‘hypervirulence’ in Clostridium difficile ' () 300 International Journal of Medical Microbiology : 387 -395 .
-
Chapman, C.M., Gibson, G.R. and Rowland, I., 2011. Health benefits of probiotics: are mixtures more effective than single strains? European Journal of Nutrition 50:1-17.
'Health benefits of probiotics: are mixtures more effective than single strains? ' () 50 European Journal of Nutrition : 1 -17 .
-
Chinen, T. and Rudensky, A.Y., 2012. The effects of commensal microbiota on immune cell subsets and inflammatory responses. Immunological Reviews 245: 45-55.
'The effects of commensal microbiota on immune cell subsets and inflammatory responses ' () 245 Immunological Reviews : 45 -55 .
-
Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., Pepin, J., Wilcox, M.H., the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America, 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology 31: 431-455.
-
De Vuyst, L., Vrancken, G., Ravyts, F., Rimaux, T. and Weckx, S., 2009. Biodiversity, ecological determinants, and metabolic exploitation of sourdough microbiota. Food Microbiology 26: 666-675.
'Biodiversity, ecological determinants, and metabolic exploitation of sourdough microbiota ' () 26 Food Microbiology : 666 -675 .
-
Dean, P., Maresca, M., Schuller, S., Phillips, A.D. and Kenny, B., 2006. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proceedings of the National Academy of Sciences of the USA 103: 1876-1881.
'Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins ' () 103 Proceedings of the National Academy of Sciences of the USA : 1876 -1881 .
-
Dockray, G.J., 2003. Luminal sensing in the gut: an overview. Journal of Physiology and Pharmacology 54 Suppl. 4: 9-17.
'Luminal sensing in the gut: an overview ' () 54 Journal of Physiology and Pharmacology : 9 -17 .
-
Ege, M.J., Mayer, M., Normand, A.C., Genuneit, J., Cookson, W.O., Braun-Fahrlander, C., Heederik, D., Piarroux, R. and Von Mutius, E. for the GABRIELA Transregio 22 Study Group, 2011. Exposure to environmental microorganisms and childhood asthma. New England Journal of Medicine 364: 701-709.
-
Feleszko, W., Jaworska, J. and Hamelmann, E., 2006. Toll-like receptors - novel targets in allergic airway disease (probiotics, friends and relatives). European Journal of Pharmacology 533: 308-318.
'Toll-like receptors - novel targets in allergic airway disease (probiotics, friends and relatives) ' () 533 European Journal of Pharmacology : 308 -318 .
-
Floch, M.H., Walker, W.A., Madsen, K., Sanders, M.E., Macfarlane, G.T., Flint, H.J., Dieleman, L.A., Ringel, Y., Guandalini, S., Kelly, C.P. and Brandt, L.J., 2011. Recommendations for probiotic use - 2011 update. Journal of Clinical Gastroenterology 45 Suppl.: S168-S171.
-
Guarner, F., Bourdet-Sicard, R., Brandtzaeg, P., Gill, H.S., McGuirk, P., Van Eden, W., Versalovic, J., Weinstock, J.V. and Rook, G.A., 2006. Mechanisms of disease: the hygiene hypothesis revisited. Nature Clinical Practice: Gastroenterology & Hepatology 3: 275-284.
'Mechanisms of disease: the hygiene hypothesis revisited ' () 3 Nature Clinical Practice: Gastroenterology & Hepatology : 275 -284 .
-
Hall, I.C. and O’Toole, E., 1935. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficile. American Journal of Diseases in Childhood 49: 390-402.
'Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficile. ' () 49 American Journal of Diseases in Childhood : 390 -402 .
-
Hautmann, M.G., Hipp, M. and Kolbl, O., 2011. Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment? Radiation Oncology 6: 89.
'Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment? ' () 6 Radiation Oncology : 89 -.
-
Hayashi, H., Szaszi, K., Coady-Osberg, N., Furuya, W., Bretscher, A.P., Orlowski, J. and Grinstein, S., 2004. Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B. Journal of General Physiology 123: 491-504.
'Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B ' () 123 Journal of General Physiology : 491 -504 .
-
Hell, M., Permoser, M., Chmelizek, G., Kern, J.M., Maass, M., Huhulescu, S., Indra, A. and Allerberger, F., 2011. Clostridium difficile infection: monoclonal or polyclonal genesis? Infection 39: 461-465.
'Clostridium difficile infection: monoclonal or polyclonal genesis? ' () 39 Infection : 461 -465 .
-
Hell, M., Sickau, K., Chmelizek, G., Kern, J.M., Maass, M., Huhulescu, S. and Allerberger, F., 2012. Absence of Clostridium difficile in asymptomatic hospital staff. American Journal of Infection Control 40: 1023-1024.
'Absence of Clostridium difficile in asymptomatic hospital staff ' () 40 American Journal of Infection Control : 1023 -1024 .
-
Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N., Shanman, R., Johnsen, B. and Shekelle, P.G., 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. Journal of the American Medical Association 307: 1959-1969.
'Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis ' () 307 Journal of the American Medical Association : 1959 -1969 .
-
Heuvelin, E., Lebreton, C., Bichara, M., Cerf-Bensussan, N. and Heyman, M., 2010. A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. Journal of Nutrition 140: 7-11.
'A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells ' () 140 Journal of Nutrition : 7 -11 .
-
Hickson, M., 2011. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therapeutic Advances in Gastroenterology 4: 185-197.
'Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection ' () 4 Therapeutic Advances in Gastroenterology : 185 -197 .
-
Hodges, K. and Gill, R., 2010. Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes 1: 4-21.
'Infectious diarrhea: cellular and molecular mechanisms ' () 1 Gut Microbes : 4 -21 .
-
Ishihara, E., Nagahama, M., Naruse, S., Semba, R., Miura, T., Usami, M. and Narita, M., 2008. Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats. Autonomic Neuroscience 138: 31-40.
'Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats ' () 138 Autonomic Neuroscience : 31 -40 .
-
Islam, J., Cohen, J., Rajkumar, C. and Llewelyn, M.J., 2012. Probiotics for the prevention and treatment of Clostridium difficile in older patients. Age and Ageing 41: 706-711.
'Probiotics for the prevention and treatment of Clostridium difficile in older patients ' () 41 Age and Ageing : 706 -711 .
-
Johnston, B.C., Ma, S.S., Goldenberg, J.Z., Thorlund, K., Vandvik, P.O., Loeb, M. and Guyatt, G.H., 2012. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Annals of Internal Medicine 157: 878-888.
'Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis ' () 157 Annals of Internal Medicine : 878 -888 .
-
Karczewski, J., Troost, F.J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.J. and Wells, J.M., 2010. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. American Journal of Physiology - Gastrointestinal and Liver Physiology 298: G851-859.
'Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier ' () 298 American Journal of Physiology - Gastrointestinal and Liver Physiology : G851 -859 .
-
Kelly, C.P., 2009. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. Journal of the American Medical Association 301: 954-962.
'A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection ' () 301 Journal of the American Medical Association : 954 -962 .
-
Kelly, G., 2008. Inulin-type prebiotics - a review: part 1. Alternative Medicine Review 13: 315-329.
'Inulin-type prebiotics - a review: part 1 ' () 13 Alternative Medicine Review : 315 -329 .
-
Kyne, L., Warny, M., Qamar, A. and Kelly, C.P., 2000. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. New England Journal of Medicine 342: 390-397.
'Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A ' () 342 New England Journal of Medicine : 390 -397 .
-
Louie, T.J., Cannon, K., Byrne, B., Emery, J., Ward, L., Eyben, M. and Krulicki, W., 2012. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clinical Infectious Diseases 55 Suppl. 2: S132-142.
'Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI ' () 55 Clinical Infectious Diseases : S132 -142 .
-
Malaguarnera, G., Leggio, F., Vacante, M., Motta, M., Giordano, M., Bondi, A., Basile, F., Mastrojeni, S., Mistretta, A., Malaguarnera, M., Toscano, M.A. and Salmeri, M., 2012. Probiotics in the gastrointestinal diseases of the elderly. The Journal of Nutrition, Health and Aging 16: 402-410.
'Probiotics in the gastrointestinal diseases of the elderly ' () 16 The Journal of Nutrition, Health and Aging : 402 -410 .
-
Malakooti, J., Saksena, S., Gill, R.K. and Dudeja, P.K., 2011. Transcriptional regulation of the intestinal luminal Na(+) and Cl(-) transporters. Biochemical Journal 435: 313-325.
'Transcriptional regulation of the intestinal luminal Na(+) and Cl(-) transporters ' () 435 Biochemical Journal : 313 -325 .
-
McFarland, L.V., 2011. Emerging therapies for Clostridium difficile infections. Expert Opinion in Emerging Drugs 16: 425-439.
'Emerging therapies for Clostridium difficile infections ' () 16 Expert Opinion in Emerging Drugs : 425 -439 .
-
Mercenier, A., Muller-Alouf, H. and Grangette, C., 2000. Lactic acid bacteria as live vaccines. Current Issues in Molecular Biology 2: 17-25.
'Lactic acid bacteria as live vaccines ' () 2 Current Issues in Molecular Biology : 17 -25 .
-
Morishima, T., Aoyama, M., Iida, Y., Yamamoto, N., Hirate, H., Arima, H., Fujita, Y., Sasano, H., Tsuda, T., Katsuya, H., Asai, K. and Sobue, K., 2008. Lactic acid increases aquaporin 4 expression on the cell membrane of cultured rat astrocytes. Neuroscience Research 61: 18-26.
'Lactic acid increases aquaporin 4 expression on the cell membrane of cultured rat astrocytes ' () 61 Neuroscience Research : 18 -26 .
-
Morrow, L.E., Gogineni, V. and Malesker, M.A., 2012. Probiotic, prebiotic, and symbiotic use in critically ill patients. Current Opinion in Critical Care 18: 186-191.
'Probiotic, prebiotic, and symbiotic use in critically ill patients ' () 18 Current Opinion in Critical Care : 186 -191 .
-
Moudgal, V. and Sobel, J.D., 2012. Clostridium difficile colitis: a review. Hospital Practice 40: 139-148.
'Clostridium difficile colitis: a review ' () 40 Hospital Practice : 139 -148 .
-
Nakatsuji, T. and Gallo, R.L., 2012. Antimicrobial peptides: old molecules with new ideas. Journal of Investigative Dermatology 132: 887-895.
'Antimicrobial peptides: old molecules with new ideas ' () 132 Journal of Investigative Dermatology : 887 -895 .
-
Nguyen, C.A., Akiba, Y. and Kaunitz, J.D., 2012. Recent advances in gut nutrient chemosensing. Current Medicinal Chemistry 19: 28-34.
'Recent advances in gut nutrient chemosensing ' () 19 Current Medicinal Chemistry : 28 -34 .
-
Ohland, C.L., DeVinney, R. and MacNaughton, W.K., 2012. Escherichia coli-induced epithelial hyporesponsiveness to secretagogues is associated with altered CFTR localization. Cellular Microbiology 14: 447-459.
'Escherichia coli-induced epithelial hyporesponsiveness to secretagogues is associated with altered CFTR localization ' () 14 Cellular Microbiology : 447 -459 .
-
Olive, C., 2012. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Review of Vaccines 11: 237-256.
'Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants ' () 11 Expert Review of Vaccines : 237 -256 .
-
Parkes, G.C., Sanderson, J.D. and Whelan, K., 2009. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infectious Diseases 9: 237-244.
'The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea ' () 9 Lancet Infectious Diseases : 237 -244 .
-
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.F., Ardid, D. and Desreumaux, P., 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13: 35-37.
'Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors ' () 13 Nature Medicine : 35 -37 .
-
Saadoun, S. and Papadopoulos, M.C., 2010. Aquaporin-4 in brain and spinal cord oedema. Neuroscience 168: 1036-1046.
'Aquaporin-4 in brain and spinal cord oedema ' () 168 Neuroscience : 1036 -1046 .
-
Salzman, N.H., Underwood, M.A. and Bevins, C.L., 2007. Paneth cells, defensins, and the commensal microbiotal: a hypothesis on intimate interplay at the intestinal mucosa. Seminars in Immunology 19: 70-83.
'Paneth cells, defensins, and the commensal microbiotal: a hypothesis on intimate interplay at the intestinal mucosa ' () 19 Seminars in Immunology : 70 -83 .
-
Sherman, P.M., Ossa, J.C. and Johnson-Henry, K., 2009. Unraveling mechanisms of action of probiotics. Nutrition in Clinical Practice 24: 10-14.
'Unraveling mechanisms of action of probiotics ' () 24 Nutrition in Clinical Practice : 10 -14 .
-
Singla, A., Kumar, A., Priyamvada, S., Tahniyath, M., Saksena, S., Gill, R.K., Alrefai, W.A. and Dudeja, P.K., 2012. LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and c-Fos-dependent pathway. American Journal of Physiology -Gastrointestinal and Liver Physiology 302: G618-G627.
'LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and c-Fos-dependent pathway ' () 302 American Journal of Physiology -Gastrointestinal and Liver Physiology : G618 -G627 .
-
Swartz, T.D., Duca, F.A., De Wouters, T., Sakar, Y. and Covasa, M., 2012. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. British Journal of Nutrition 107: 621-630.
'Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota ' () 107 British Journal of Nutrition : 621 -630 .
-
Tschudin-Sutter, S., Widmer, A.F. and Perl, T.M., 2012. Clostridium difficile: novel insights on an incessantly challenging disease. Current Opinion in Infectious Diseases 25: 405-411.
'Clostridium difficile: novel insights on an incessantly challenging disease ' () 25 Current Opinion in Infectious Diseases : 405 -411 .
-
Ulluwishewa, D., Anderson, R.C., McNabb, W.C., Moughan, P.J., Wells, J.M. and Roy, N.C., 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. Journal of Nutrition 141: 769-776.
'Regulation of tight junction permeability by intestinal bacteria and dietary components ' () 141 Journal of Nutrition : 769 -776 .
-
Van Baarlen, P., Troost, F., Van der Meer, C., Hooiveld, G., Boekschoten, M., Brummer, R.J.M. and Kleerebezem, M., 2011. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proceedings of the National Academy of Sciences of the USA 108 Suppl. 1: 4562-4569.
'Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways ' () 108 Proceedings of the National Academy of Sciences of the USA : 4562 -4569 .
-
Van Baarlen, P., Troost, F., Van Hemert, S., Van der Meer, C., De Vos, W.M., De Groot, P.J., Hooiveld, G.J.E.J., Brummer, R.J.M. and Kleerebezem, M., 2009. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proceedings of the National Academy of Sciences of the USA 106: 2371-2376.
'Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance ' () 106 Proceedings of the National Academy of Sciences of the USA : 2371 -2376 .
-
Van Driel, I.R. and Ang, D.K., 2008. Role of regulatory T cells in gastrointestinal inflammatory disease. Journal of Gastroenterology and Hepatology 23: 171-177.
'Role of regulatory T cells in gastrointestinal inflammatory disease ' () 23 Journal of Gastroenterology and Hepatology : 171 -177 .
-
Van Huynegem, K., Loos, M. and Steidler, L., 2009. Immunomodulation by genetically engineered lactic acid bacteria. Frontiers in Bioscience 14: 4825-4835.
'Immunomodulation by genetically engineered lactic acid bacteria ' () 14 Frontiers in Bioscience : 4825 -4835 .
-
Van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., De Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F., Tijssen, J.G., Speelman, P., Dijkgraaf, M.G. and Keller, J.J., 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. New England Journal of Medicine 368: 407-415.
'Duodenal infusion of donor feces for recurrent Clostridium difficile ' () 368 New England Journal of Medicine : 407 -415 .
-
Verna, E.C. and Lucak, S., 2010. Use of probiotics in gastrointestinal disorders: what to recommend? Therapeutic Advances in Gastroenterology 3: 307-319.
'Use of probiotics in gastrointestinal disorders: what to recommend? ' () 3 Therapeutic Advances in Gastroenterology : 307 -319 .
-
Veshnyakova, A., Piontek, J., Protze, J., Waziri, N., Heise, I. and Krause, G., 2012. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. Journal of Biological Chemistry 287: 1698-1708.
'Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins ' () 287 Journal of Biological Chemistry : 1698 -1708 .
-
Videlock, E.J. and Cremonini, F., 2012. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics 35: 1355-1369.
'Meta-analysis: probiotics in antibiotic-associated diarrhoea ' () 35 Alimentary Pharmacology and Therapeutics : 1355 -1369 .
-
Wells, J.M., 2011. Immunomodulatory mechanisms of lactobacilli. Microbial Cell Factories 10 Suppl. 1: S17.
-
Wolvers, D., Antoine, J.M., Myllyluoma, E., Schrezenmeir, J., Szajewska, H. and Rijkers, G.T., 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. Journal of Nutrition 140: 698S-712S.
'Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics ' () 140 Journal of Nutrition : 698S -712S .
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 89 | 87 | 12 |
| PDF Views & Downloads | 113 | 112 | 13 |
Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic
In: Beneficial MicrobesSearch for other papers by M. Hell in
Current site
Google Scholar
PubMed
Search for other papers by C. Bernhofer in
Current site
Google Scholar
PubMed
Search for other papers by P. Stalzer in
Current site
Google Scholar
PubMed
Search for other papers by J.M. Kern in
Current site
Google Scholar
PubMed
Search for other papers by E. Claassen in
Current site
Google Scholar
PubMed
In the past two years an enormous amount of molecular, genetic, metabolomic and mechanistic data on the host-bacterium interaction, a healthy gut microbiota and a possible role for probiotics in Clostridium difficile infection (CDI) has been accumulated. Also, new hypervirulent strains of C. difficile have emerged. Yet, clinical trials in CDI have been less promising than in antibiotic associated diarrhoea in general, with more meta-analysis than primary papers on CDI-clinical-trials. The fact that C. difficile is a spore former, producing at least three different toxins has not yet been incorporated in the rational design of probiotics for (recurrent) CDI. Here we postulate that the plethora of effects of C. difficile and the vast amount of data on the role of commensal gut residents and probiotics point towards a multistrain mixture of probiotics to reduce CDI, but also to limit (nosocomial) transmission and/or endogenous reinfection. On the basis of a retrospective chart review of a series of ten CDI patients where recurrence was expected, all patients on adjunctive probiotic therapy with multistrain cocktail (Ecologic®AAD/OMNiBiOTiC® 10) showed complete clinical resolution. This result, and recent success in faecal transplants in CDI treatment, are supportive for the rational design of multistrain probiotics for CDI.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 89 | 87 | 12 |
| PDF Views & Downloads | 113 | 112 | 13 |